Can Sun Pharma Shares Rally Toward ₹2,000? SEBI RA Manish Kushwaha Pins Move On Weekly Breakout

The current Sun Pharma price movement remains trapped between two converging trendlines, showing a narrowing trading range, according to SEBI-registered analyst Manish Kushwaha. 

The increasingly lower trendline has maintained steady support as price movements show robust rebounds near this point. 

In contrast, the decreasing upper trendline has repeatedly restricted upward progress, causing numerous price failures. 

At the time of writing, Sun Pharma shares were trading at ₹1,670.4, down ₹48.3 or 2.8%.

The level at ₹1,525, which marks the 38.2% Fibonacci retracement, stands as an essential support zone that strengthens the lower boundary of the trading range. 

This stock has a current trading price of ₹1,724.70 and a relative strength index (RSI) value of 48.38, indicating neutral market momentum without being overbought or oversold. 

Kushwaha said that a decisive weekly break above the resistance zone between ₹1,750 and ₹1,780 will signal an upward trend toward the former high of ₹1,950 to ₹2,000, provided there is significant trading activity. 

The stock will likely stay within its converging pattern until a breakout happens, but traders will continue to monitor these critical technical levels for direction.

On Stocktwits, retail sentiment was ‘neutral’ amid ‘high’ message volume.

The stock has declined 11.6% so far in 2025.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on